Filing Flows

Filing Flows › Charles River Laboratories International (CRL) › Q4 2025

Charles River Laboratories International (CRL) Q4 2025 earnings results (fourth quarter 2025)

10-K filed Feb 18, 2026

Charles River Laboratories International (CRL) reported revenue of $994M for the fourth quarter 2025 (Q4 2025), -0.8% from a year earlier and -1% from the quarter before. Operating margin was -28.5%, net loss $276M (27.8% of revenue).

Revenue$994M
Year over year-0.8%
Quarter over quarter-1%
Operating margin-28.5%
Net earnings−$276M

Charles River Laboratories International, Q4 2025: revenue $994M (-0.8% year over year), operating margin -28.5%, net loss $276M, operating cash flow $148M. The chart follows the revenue to costs, profit and cash.

Q4 2025AmountQ/QY/Y
Revenue$994M-1%-0.8%
Operating profit−$283M-312%—
Net earnings−$276M-608%—
Operating cash flow$148M-31%-7%
Free cash flow$58.6M-67%-30%

What changed

Revenue was $994.2M in Q4 2025, down 1% year over year and down 1% from the previous quarter. DSA was the largest line at 60% of revenue.

Operating costs exceeded revenue by $283.4M, an operating margin of -28.5%. Total costs grew 9% against a revenue fall of 1%. The fastest-growing cost line was Other operating costs (+11%). The quarter ended with a net loss of $276.3M, after a profit of $55.6M the previous quarter.

Operating cash flow was $147.5M (down 7% year over year). Non-cash charges added back $78.3M of depreciation and amortization and $17.6M of share-based compensation. Working capital and other items added $327.9M. Capital expenditures of $89.0M left free cash flow of $58.6M.

Questions

What was Charles River Laboratories International's revenue in the fourth quarter 2025?

Charles River Laboratories International (CRL) reported revenue of $994M for the fourth quarter 2025 (Q4 2025), -0.8% from a year earlier and -1% from the quarter before.

Was Charles River Laboratories International profitable in the fourth quarter 2025?

Operating loss was $283M (-28.5% of revenue) and net loss $276M.

Open the interactive Sankey →

Source: Charles River Laboratories International 10-K on SEC EDGAR.